NDT Advance Access originally published online on February 8, 2005
Nephrology Dialysis Transplantation 2005 20(4):719-727; doi:10.1093/ndt/gfh716
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Characteristics and risk factors of intrarenal arterial lesions in patients with IgA nephropathy
Kidney Center of PLA, Department of Nephrology, Chinese General Hospital of PLA, Beijing, China
Correspondence and offprint requests to: Prof. Xiangmei Chen, Kidney Center of PLA, Department of Nephrology, Chinese General Hospital of PLA, Fuxing Road 28, Beijing 100853, China. Email: xmchen{at}public.bta.net.cn
Background. Although the clinical importance of immunoglobulin-A nephropathy (IgAN) is widely recognized, the characteristics of intrarenal arterial lesions in this disease and the main factors associated with them have not been studied extensively, and a large-scale analysis of intrarenal arterial lesions in IgAN has not been performed.
Methods. To clarify these issues, we investigated the prevalence, underlying factors and significance of intrarenal arterial lesions in 1005 patients with IgAN. We distinguished different degrees of severity of small artery and arteriolar lesions (mild, moderate and severe), using a semi-quantitative scoring system. We compared the arterial lesions of IgAN patients with those of 627 non-IgAN patients, who had mesangial proliferating glomerulonephritis without IgA deposits, and of 221 patients with membranous nephropathy (MN).
Results. The IgAN patients with arterial lesions were significantly younger than the non-IgAN and MN patients (mean ages 34.6 vs 40.4 and 47.7 years, respectively). The prevalence of intrarenal small artery and arteriolar lesions was 54.6% in IgAN patients, compared with 26.6 and 47.1% in non-IgAN and MN patients, respectively; the percentages of moderate/severe arterial lesions were 37.0 vs 21.6 and 23.1%, respectively; and the percentages of hyaline changes were 43.7 vs 16.8 and 21.2%, respectively. The differences in the prevalence of lesions between IgAN patients and the two other groups were statistically significant for all three parameters. Our search for possible relationships between arterial–arteriolar lesions and various indirect outcome markers disclosed significant associations with hypertension, higher serum creatinine and uric acid, high urinary protein excretion, glomerulosclerosis, tubular atrophy and interstitial fibrosis. Furthermore, these parameters were changed more markedly in IgAN patients with moderate/severe arterial lesions and hyaline changes than in IgAN patients who had mild arterial lesions and wall thickening alone.
Conclusions. The prevalence of small intrarenal arterial–arteriolar lesions was higher in IgAN patients than in non-IgAN and MN patients; moreover, the lesions in IgAN patients were associated with younger age, were more severe and exhibited a higher degree of hyaline changes. Finally, the severity of small arterial– arteriolar lesions was linked to several markers of adverse outcome.
Keywords: arterial hyaline changes; immunoglobulin-A nephropathy; intrarenal arterial lesions
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Z. Avram and E. Krishnan Hyperuricaemia--where nephrology meets rheumatology Rheumatology, July 1, 2008; 47(7): 960 - 964. [Abstract] [Full Text] [PDF]
|
|